SCHEMBL17900416

SCHEMBL17900416

CCC[C@H](C)n1c(Cc2cc(OC)c(OC)c(OC)c2)nc2c(N)ncnc21

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 11/20 0.67
▸ HSP90AB1 P08238 11/20 0.67
▸ ERBB2 P04626 2/20 0.67
▸ HSP90B1 P14625 2/20 0.49
▸ ADORA3 P0DMS8 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA2B P29275 1/20 0.44
▸ ADORA1 P30542 1/20 0.44
▸ MEN1 O00255 1/20 0.41
▸ SLC22A1 O15245 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ DHFR P00374 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17897956 0.94 HSP90AA1 (0.60) HSP90AA1HSP90AB1ERBB2HSP90B1ADORA3
SCHEMBL17900222 0.89 HSP90AA1 (0.68) HSP90AA1HSP90AB1ERBB2ADORA3ADORA2A
SCHEMBL17897955 0.83 HSP90AA1 (0.61) HSP90AA1HSP90AB1ERBB2ADORA3ADORA2A
SCHEMBL14456059 0.81 HSP90AA1 (0.72) HSP90AA1HSP90AB1ERBB2ADORA2AADORA2B
SCHEMBL21861885 0.80 HSP90B1 (0.73) HSP90AA1HSP90AB1ERBB2HSP90B1
SCHEMBL2604975 0.80 HSP90AA1 (1.00) HSP90AA1HSP90AB1ERBB2ADORA2AADORA2B
SCHEMBL17897894 0.75 HSP90AA1 (0.70) HSP90AA1HSP90AB1ERBB2MEN1SLC22A1
SCHEMBL10149976 0.75 HSP90AA1 (0.89) HSP90AA1HSP90AB1ERBB2ADORA2AADORA2B
SCHEMBL1964163 0.72 HSP90AA1 (0.86) HSP90AA1HSP90AB1ERBB2ADORA2AADORA2B
SCHEMBL14044861 0.71 HSP90AA1 (0.83) HSP90AA1HSP90AB1ERBB2ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230123747-A1 SELECTIVE GRP94 INHIBITORS AND USES THEREOF MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2023-04-20 — — US disclosed
US-20200102312-A1 SELECTIVE GRP94 INHIBITORS AND USES THEREOF MEMORIAL SLOAN-KETTERING CANCER CENTER 2020-04-02 — — US disclosed
US-10421758-B2 Selective Grp94 inhibitors and uses thereof MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2019-09-24 — — US disclosed
US-20160194328-A1 SELECTIVE GRP94 INHIBITORS AND USES THEREOF MEMORIAL SLOAN-KETTERING CANCER CENTER 2016-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194328-A1 SELECTIVE GRP94 INHIBITORS AND USES THEREOF HSP90B1, HSP90AB2P, HSPE1 HSP90AA1 9/4885HSP90AB1 4/4885ERBB2 725/4885
US-10421758-B2 Selective Grp94 inhibitors and uses thereof HSP90B1, HSP90AB2P, HSPE1 HSP90AA1 9/4885HSP90AB1 4/4885ERBB2 725/4885
US-20200102312-A1 SELECTIVE GRP94 INHIBITORS AND USES THEREOF HSP90B1, HSP90AB2P, HSPE1 HSP90AA1 9/4885HSP90AB1 4/4885ERBB2 725/4885
US-20230123747-A1 SELECTIVE GRP94 INHIBITORS AND USES THEREOF HSP90B1, HSP90AB2P, HSPE1 HSP90AA1 9/4885HSP90AB1 4/4885ERBB2 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback